Skip to main content
Top
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Research

Cost and availability of selected medicines after implementation of increased import verification fees

Authors: Helen Byomire Ndagije, Diana Nakitto Kesi, Kalidi Rajab, Solomon Onen, Allan Serwanga, Leonard Manirakiza, Sheila Ampaire, Joseph Mutasaaga, Denis Mwesigwa, David Nahamya

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Uganda imports approximately 90% of its medicines, with about 60% being distributed by the private sector. To discourage importation and promote local production of 37 selected locally manufactured medicines, the Ugandan government through the Ministry of Health in 2017 increased the import verification fees from 2 to 12%. The increase in verification fees ultimately affects cost and availability of these medicines. This study aimed to assess the cost and availability of the selected essential medicines after the 12% increase in verification fees in Uganda.

Methods

A cross sectional study among 328 wholesale and retail pharmacies and seven key informant interviews was conducted using a pretested data collection checklist and in-depth interview guide from February to September 2021 in Uganda. Data on the availability and prices of the medicines before (2017) and after (2020) the increase in verification fees was collected. Paired sample T-Test was used to test if there is a significant difference in prices before and after the 12% increase in verification fees.

Results

Mean availability of imported medicines was higher (54.8%, CI: 49.3–60.4) than the locally produced medicines (37.1%, CI: 31.9–42.7) except for locally manufactured parenteral preparations (54.6.%, CI: 49.1–60.1). Availability of locally produced medicines was mainly low (45%) while the imported medicines were fairly high (74%). Most commonly available locally manufactured medicines were Surgical spirit (89.9%), ORS (86%), Dextrose 5% solution (74.4%), Paracetamol 500 mg Tablets (73.8%) and Sodium Chloride 0.9% solution (72.9%). Most commonly available imported medicines were; Omeprazole 20 mg (94.2%), Amoxicillin Trihydrate 125 mg/5 ml (92.4%), Ciprofloxacin 500 mg (91.4%), Paracetamol Suspension 120 mg/5 ml (91.5%) and Metronidazole 200 mg Tablets (88.1%). Increase in lowest-priced local and imported medicines was significant for 10 (23.8%) and 7 (15.9%) of the medicines respectively. The median prices of imported medicines were generally higher than locally produced medicines. The median unit prices of 12 (28.6%) locally produced medicines and 20 (47.6%) imported medicines were higher than the international median unit prices.

Conclusions

The overall availability of imported medicines was still higher than the local medicines. The median prices of local and imported medicines generally increased or remained the same after the introduction of import verification fees. There is a need for price controls and transparency in the private sector.
Appendix
Available only for authorised users
Literature
Metadata
Title
Cost and availability of selected medicines after implementation of increased import verification fees
Authors
Helen Byomire Ndagije
Diana Nakitto Kesi
Kalidi Rajab
Solomon Onen
Allan Serwanga
Leonard Manirakiza
Sheila Ampaire
Joseph Mutasaaga
Denis Mwesigwa
David Nahamya
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-023-10433-7

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue